Hollander David — SEC Form 4 filings
SEC reporting owner CIK 1793796. 6 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-07-03 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,908 shares, $16,296 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 3,908 shares @ $4.17 ($16,296) in Revance Therapeutics, Inc., filed 2024-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Revance Therapeutics, Inc. (RVNC) | CMO & Global Therapeutics Lead | 2 | — | 1 leg · 3,908 sh · $16,296 | 2 |
| KIORA PHARMACEUTICALS INC (KPRX) | Director | 3 | — | — | 3 |
| Veradermics, Inc (MANE) | Chief R&D Officer | 1 | — | — | 2 |
Form 4 filings — Hollander David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Veradermics, Inc (MANE) | Grant/award (A): 9,650 @ $0 · Grant/award (A): 19,300 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | KIORA PHARMACEUTICALS INC (KPRX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | KIORA PHARMACEUTICALS INC (KPRX) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Revance Therapeutics, Inc. (RVNC) | Code (U): 9,733 @ $3.65 · Disposition to issuer (D): 95,212 | EDGAR |
| 2024-11-19 | 4 | Revance Therapeutics, Inc. (RVNC) | Sale (S): 3,908 @ $4.17 | EDGAR |
| 2024-07-03 | 4 | KIORA PHARMACEUTICALS INC (KPRX) | Grant/award (A): 1,778 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1793796 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →